Related Experiment Video

Updated: Aug 22, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Raf kinase inhibitory protein inhibits beta-cell proliferation

Lizhi Zhang1, Zheng Fu, Charles Binkley

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor, Mich, USA.

Surgery
|September 7, 2004
PubMed
Abstract

Insights

Raf-1 kinase inhibitory protein (RKIP) is expressed in pancreatic islet cells and inhibits beta-cell proliferation. Downregulation of RKIP may contribute to islet tumors like insulinomas.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Raf-1 kinase inhibitory protein (RKIP) is an endogenous inhibitor of the extracellular signal-regulated kinase (ERK) pathway.
  • The expression and function of RKIP in the pancreas were previously unknown.

Purpose of the Study:

  • To investigate RKIP expression in normal pancreatic islet cells and human insulinomas.
  • To determine the role of RKIP in beta-cell proliferation and its effect on the ERK signaling pathway.

Main Methods:

  • RKIP expression analyzed using immunohistochemistry on pancreatic sections.
  • RKIP co-localization with endocrine markers via immunofluorescence.
  • RKIP's effect on ERK signaling and beta-cell proliferation studied in HIT-T15 cells using Western blotting, MTS assay, and FACS analysis.

Main Results:

  • RKIP is expressed in pancreatic islet cells, particularly beta cells.
  • RKIP expression was significantly downregulated in most human insulinomas.
  • RKIP inhibited beta-cell proliferation by affecting cell cycle distribution and blocked MEK/ERK activation.

Conclusions:

  • RKIP plays a crucial role in regulating beta-cell proliferation.
  • Downregulation of RKIP may be implicated in the development of islet cell tumors, such as insulinomas.

More Related Videos

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...